NCT03761004View on ClinicalTrials.gov

WD-1603 PK Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

September 5, 2019

Study Completion Date

September 5, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

carbidopa-levodopa

single dose of WD-1603, BID dose of WD-1603 and Sinemet IR

Trial Locations (1)

Unknown

INC Research Toronto, Inc., Toronto

All Listed Sponsors
lead

Hong Kong WD Pharmaceutical Co., Limited

INDUSTRY

NCT03761004 - WD-1603 PK Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter